MayoHemeOnc Profile Banner
Mayo Clinic Hematology-Oncology Fellowship Profile
Mayo Clinic Hematology-Oncology Fellowship

@MayoHemeOnc

Followers
4K
Following
518
Media
94
Statuses
587

Official Twitter of the Hematology-Oncology Fellowship Program at Mayo Clinic, Rochester, MN Instagram: mayohemeoncfellowship_mn

Rochester, MN
Joined May 2019
Don't wanna be here? Send us removal request.
@MayoHemeOnc
Mayo Clinic Hematology-Oncology Fellowship
27 days
RT @OncoThor: That's a good review on CUPs that addresses the utility of IHC and genomics in the management of this fascinating group of ca….
0
1
0
@MayoHemeOnc
Mayo Clinic Hematology-Oncology Fellowship
1 month
RT @NarjustFlorezMD: Are you a third year fellow? Or in your last year of training? . We are starting a new series about finding that first….
0
8
0
@grok
Grok
6 days
Join millions who have switched to Grok.
242
482
4K
@MayoHemeOnc
Mayo Clinic Hematology-Oncology Fellowship
1 month
RT @OncoThor: Want to know more about clonal hematopoesis in myeloid malignancies and solid tumors? If so, here is a weekend read for you. ….
Tweet card summary image
nature.com
Nature Cancer - Trowbridge and colleagues provide a comprehensive review of clonal hematopoiesis in diverse cancer settings, from myeloid malignancies to solid tumors, covering underlying molecular...
0
2
0
@MayoHemeOnc
Mayo Clinic Hematology-Oncology Fellowship
1 month
RT @LauraAlderMD: Terrific presentation on utilization of social media, by the master @StephenVLiu! .Personally, have learned so much and….
0
6
0
@MayoHemeOnc
Mayo Clinic Hematology-Oncology Fellowship
1 month
19M presents with two months left thigh pain. Radiographs reveal lytic lesion and periosteal reaction in diaphysis of femur. Biopsy shows round blue cells and t(11;22) (q24;q12) translocation. What’s the preferred treatment modality?.
0
0
0
@MayoHemeOnc
Mayo Clinic Hematology-Oncology Fellowship
1 month
A 53F presented with severe bruising and prolonged bleeding following hospitalization for an infection. PT 35s, aPTT 45s, plt 222, fibrgn nl, mix study shows PT correction, FV nl, FVII low, FX low, FVIII nl, FII low. What’s most likely cause of bleeding?.
1
0
2
@MayoHemeOnc
Mayo Clinic Hematology-Oncology Fellowship
1 month
Friday Review time! .This week we discussed coagulopathies and bone sarcomas. Test your knowledge below!.
1
0
2
@MayoHemeOnc
Mayo Clinic Hematology-Oncology Fellowship
1 month
Excellent journal club presentation by @emmacstmartinMD & @EmperorBlackMD on practice changing trials in SCLC!
Tweet media one
Tweet media two
0
0
8
@MayoHemeOnc
Mayo Clinic Hematology-Oncology Fellowship
1 month
Dr Robinson providing an interactive session on bone sarcomas! 🦴🦀.#Onc #sarcoma #OncTwitter #HemeOnc
Tweet media one
0
0
2
@MayoHemeOnc
Mayo Clinic Hematology-Oncology Fellowship
1 month
RT @OncoThor: Oligometastatic colorectal lung metastases. Resection or SBRT. Are you as curious as I am about those options? If so, here….
0
3
0
@MayoHemeOnc
Mayo Clinic Hematology-Oncology Fellowship
1 month
The incomparable Dr Pruthi providing an overview of coagulopathies! #hematology #heme #hemepath
Tweet media one
0
0
9
@MayoHemeOnc
Mayo Clinic Hematology-Oncology Fellowship
1 month
You’re a rockstar, Olisa!.
@olisaogbue
Olisaemeka Ogbue, MD
1 month
Wrapping up an inspiring Day 2 @AACR MBCO workshop with an insightful talk on cancer dependencies and 10 essential tips for building a successful career in academic oncology. #Oncology #CancerResearch #CareerDevelopment @MayoHemeOnc
Tweet media one
Tweet media two
0
0
4
@MayoHemeOnc
Mayo Clinic Hematology-Oncology Fellowship
1 month
Proud of this amazing fellow!.
@SyedaMinaMD
Syeda Mina
1 month
Day 1 of the @ASCO / @AACR methods in clinical cancer research ✅ great start to a rigorous week of learning and reflecting, so excited to see how the protocol takes shape! #vailworkshop #MCCR25
Tweet media one
Tweet media two
Tweet media three
0
0
6
@MayoHemeOnc
Mayo Clinic Hematology-Oncology Fellowship
1 month
Tweet media one
Tweet media two
0
0
18
@MayoHemeOnc
Mayo Clinic Hematology-Oncology Fellowship
1 month
RT @hsafaMD: 🩸Hematology for The Non-Hematologist🩸. (An educational series for internal medicine trainees and physicians, aiming to make he….
0
21
0
@MayoHemeOnc
Mayo Clinic Hematology-Oncology Fellowship
1 month
RT @OncoThor: @DrKatePedersen giving us critical information on practice changing trials in colorectal cancer management such as BREAKWATER….
0
2
0
@MayoHemeOnc
Mayo Clinic Hematology-Oncology Fellowship
2 months
RT @OncoThor: And now into the head and neck region. As expected, Dr. Katharine Price delivers an outstanding presentation on advances in h….
0
5
0
@MayoHemeOnc
Mayo Clinic Hematology-Oncology Fellowship
2 months
RT @OncoThor: And it is on! The annual Mayo Oncology review in Minneapolis. First on the podium, Dan Childs from GU oncology at Mayo Roches….
0
4
0
@MayoHemeOnc
Mayo Clinic Hematology-Oncology Fellowship
2 months
A patient with metastatic GIST harboring a KIT exon 9 mutation progresses on imatinib 400 mg daily after 8 months of therapy. What is the recommended next step?.
0
0
1
@MayoHemeOnc
Mayo Clinic Hematology-Oncology Fellowship
2 months
A 63-year-old woman undergoes complete resection of a 7 cm gastric GIST with 8 mitoses per 50 high-power fields (HPFs). Mutation testing reveals a KIT exon 11 mutation. What is the recommended adjuvant tx?.
1
0
0